跳至主要内容
临床试验/NCT04810663
NCT04810663Unknown不适用

Outcome of Radiation Therapy In Operated Gastric Cancer

Assiut University0 个研究点目标入组 40 人开始时间: 2021年4月1日最近更新:
适应症

试验速览

阶段
不适用
入组人数
40
主要终点
Efficacy of Radiotherapy in operated gastric cancer

研究概览

简要总结

  • Study tolerability and toxicity of radiotherapy with or without chemotherapy for operated gastric cancer.
  • Evaluate the efficacy of adjuvant radiotherapy with or without chemotherapy as regarding local control and overall survival.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Retrospective

入排标准

年龄范围
18 Years 至 75 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Age of the patient; ≥18 and ≤75 years.
  • Histologically proven gastric or gastroesophageal adenocarcinoma.
  • Pt received adjuvant Radiotherapy with or without chemotherapy with any protocol.

排除标准

  • Patient >75 years&<18 years.
  • Histologically types other than adenocarcinoma .
  • Metastatic patients (M1).
  • Pt didn't recive radiotherapy.

结局指标

主要结局

Efficacy of Radiotherapy in operated gastric cancer

时间窗: Baseline

Disease Free Survival

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Mohamed Ahmed Ezzat Mohamed

principal Investigator

Assiut University

相似试验

终止
4 期
The Effect of Chemoradiotherapy on Gastric Perfusion in Patients With Gastric Cancer.Gastric Cancer
NCT05354856Rigshospitalet, Denmark11
进行中(未招募)
1 期
clinical study to evaluate the efficacy of a two drug combination versus a single drug therapy in the treatment of locally advanced rectal cancer.locally advanced rectal cancerMedDRA version: 17.0Level: PTClassification code 10038050Term: Rectal cancer stage IIISystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)MedDRA version: 17.0Level: PTClassification code 10038049Term: Rectal cancer stage IISystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)
EUCTR2006-006532-21-DEEORTC1,094
进行中(未招募)
不适用
Preoperative chemoradiotherapy and postoperative chemotherapy with capecitabine and oxaliplatin vs. capecitabine alone in locally advanced rectal cancerRectal cancerLocally Advanced Rectal CancerCancer - Bowel - Back passage (rectum) or large bowel (colon)
ACTRN12608000403336Australasian Gastro-Intestinal Trials Group (AGITG)1,090
进行中(未招募)
1 期
Preoperative chemoradiotherapy and postoperative chemotherapy with capecitabine and oxaliplatin vs. capecitabine alone in locally advanced rectal cancer (PETACC-6) - PETACC-6locally advanced rectal cancerMedDRA version: 9.1Level: LLTClassification code 10038050Term: Rectal cancer stage IIIMedDRA version: 9.1Level: LLTClassification code 10038049Term: Rectal cancer stage II
EUCTR2006-006532-21-FREORTC1,090
进行中(未招募)
1 期
Preoperative chemoradiotherapy and postoperative chemotherapy with capecitabine and oxaliplatin vs. capecitabine alone in locally advanced rectal cancer (PETACC-6) - PETACC-6locally advanced rectal cancerMedDRA version: 9.1 Level: LLT Classification code 10038050 Term: Rectal cancer stage IIIMedDRA version: 9.1 Level: LLT Classification code 10038049 Term: Rectal cancer stage II
EUCTR2006-006532-21-GBEuropean Organization for Research and Treatment of Cancer1,094